The effect of PPARα and PPARγ ligands on inflammation and ABCA1 expression in cultured gallbladder epithelial cells

Digestive Diseases and Sciences

Volumn 53, Issue 6, 2008, Pages 1707-1715

  Lee, Jin ^a   Hong, Eun Mi ^a   Byun, Hyun Woo ^a   Choi, Min Ho ^a   Jang, Hyun Joo ^a   Eun, Chang Soo ^a   Kae, Sea Hyub ^a   Choi, Ho Soon ^b  

^a Hallym University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

Author keywords

ATP binding cassette transporter A1 (ABCA1); Gallbladder; Gallstone; Peroxisome proliferator activated receptor (PPAR)

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ABC TRANSPORTER A1; COLLAGEN; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; ABC TRANSPORTER;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHOLECYSTITIS; CONTROLLED STUDY; DRUG EFFECT; GALLBLADDER EPITHELIUM; GALLBLADDER FUNCTION; GALLSTONE FORMATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CYTOLOGY; DOG; EPITHELIUM CELL; GALLBLADDER; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELLS, CULTURED; DOGS; EPITHELIAL CELLS; GALLBLADDER; INFLAMMATION; LIGANDS; PPAR ALPHA; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 43049094798     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0029-5     Document Type: Article

References (50)

1. van Erpecum KJ (2005) Biliary lipids, water and cholesterol gallstones. Biol Cell 97:815-822
2. Carey MC (1993) Pathogenesis of gallstones. Am J Surg 165:410-419
3. Schoenfield LJ, Carey MC, Marks JW, Thistle JL (1989) Gallstones: an update. Am J Gastroenterol 84:999-1007
4. Xiao ZL, Biancani P, Behar J (2004) Role of PGE2 on gallbladder muscle cytoprotection of guinea pigs. Am J Physiol Gastrointest Liver Physiol 286:G82-G88
5. Rege RV (2000) Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion. J Gastrointest Surg 4:185-192
6. Corradini SG, Elisei W, Giovannelli L, Ripani C, Della Guardia P, Corsi A, Cantafora A, Capocaccia L, Ziparo V, Stipa V, Chirletti P, Caronna R, Lomanto D, Attili AF (2000) Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 118: 912-920
7. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, Oram JF (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104:R25-R31
8. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J Jr, Hayden MR (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genetics 22:336-345
9. Oram JF (2000) Tangier disease and ABCA1. Biochim Biophys Acta 1529:321-330
10. Lee J, Shirk A, Oram JF, Lee SP, Kuver R (2002) Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J 364:475-484
11. Lee J, Tauscher A, Seo DW, Oram JF, Kuver R (2003) Cultured gallbladder epithelial cells synthesize apolipoproteins A-I and E. Am J Physiol Gastrointest Liver Physiol 285:G630-G641
12. Hirakata M, Tozawa R, Imura Y, Sugiyama Y (2004) Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation. Biochem Biophys Res Commun 323:782-788
13. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 1583:841-850
14. Francis GA, Annicotte JS, Auwerx J (2003) PPAR agonists in the treatment of atherosclerosis. Curr Opin Pharmacol 3:186-191
15. Francis GA, Annicotte JS, Auwerx J (2003) PPAR-alpha effects on the heart and other vascular tissues. Am J Physiol Heart Circ Physiol 285:H1-H9
16. Daynes R, Jones DC (2002) Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759
17. Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Becuwe P, Dauca M, Netter P, Terlain B (2002) PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am J Physiol Cell Physiol 282:C125-C133
18. Ory DS (2004) Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home? Circ res 95:660-670
19. Fitzgerald ML, Moore KJ, Freeman MW (2002) Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home. J Mol Med 80: 271-281
20. Gbaguidi GF, Agellon LB (2004) The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer. Nucleic Acids Res 32:1113-1121
21. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B (2001) PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58
22. Pan GD, Wu H, Liu JW, Cheng NS, Xiong XZ, Li SF, Zhang GF, Yan LN (2005) Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells. World J Gastroenterol 11:6061-6065
23. Cha JY, Repa JJ (2007) The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282:743-751
24. Sterling RK, Shiffman ML, Sugerman HJ, Moore EW (1995) Effect of NSAIDs on gallbladder bile composition. Dig Dis Sci 40:2220-2226
25. Oda D, Lee SP, Hayashi A (1991) Long-term culture and partial characterization of dog gallbladder epithelial cells. Lab Invest 64:682-693
26. Jacyna MR, Ross PE, Bakar MA, Hopwood D, Bouchier IA (1987) Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis. J Clin Pathol 40:524-529
27. Lahera V, Goicoechea M, de Vinuesa SG, Miana M, de Las Heras N, Cachofeiro V, Luno J (2007) Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 14:243-248
28. Yang SY, Jun DW, Han SH, Yoon CO, Choi HS, Lee OY, Yoon BC, Hahm JS, Lee MH, Lee DH, Kee CS, Lee J, Kuver R, Lee SP (2005) The molecular mechanisms of cholesterol efflux by reverse cholesterol transporter (ABCA1) of human gallbladder epithelial cells. J Gastroen Hepatol 20(suppl):A304
29. Quinet EM, Savio DA, Halpern AR, Chen L, Schuster GU, Gustafsson JA, Basso MD, Nambi P (2006) Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Mol Pharmacol 70:1340-1349
30. Oram JF (2002) ABCA1 as a new therapeutic target for treating cardiovascular disease. Drug News Perspect 15:24-28
31. Costet P, Luo Y, Wang N, Tall AR (2000) Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275:28240-28245
32. Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI (2000) Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol 14:741-752
33. Vasudevan AR, Jones PH (2005) Effective use of combination lipid therapy. Curr Cardiol Rep 7:471-479
34. Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ (2005) A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care 28:1547-1554
35. Wang Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2005) Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines. J Lipid Res 46:2377-2387
36. Baranova I, Vishnyakova T, Bocharov A, Chen Z, Remaley AT, Stonik J, Eggerman TL, Patterson AP (2002) Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 70:2995-3003
37. Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR (2003) Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 2003 44:1728-1736
38. Koseki M, Hirano K, Masuda D, Ikegami C, Tanaka M, Ota A, Sandoval JC, Nakagawa-Toyama Y, Sato SB, Kobayashi T, Shimada Y, Ohno-Iwashita Y, Matsuura F, Shimomura I, Yamashita S (2007) Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-{alpha} secretion in Abca1-deficient macrophages. J Lipid Res 48:299-306
39. Kaplan R, Gan X, Menke JG, Wright SD, Cai TQ (2002) Bacterial lipopolysaccharide induces expression of ABCA1 but not ABCG1 via an LXR-independent pathway. J Lipid Res 43:952-959
40. Yoshida T, Matsuzaki Y, Haigh WG, Fukushima S, Ikezawa K, Tanaka N, Lee SP (2003) Origin of oxysterols in hepatic bile of patients with biliary infection. Am J Gastroenterol 98:2275-2280
41. Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688
42. Clark RB (2002) The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400
43. Shaffer EA (2006) Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20:981-996
44. Caroli-Bosc FX, Le Gall P, Pugliese P, Delabre B, Caroli-Bosc C, Demarquay JF, Delmont JP, Rampal P, Montet JC (2001) Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population. Dig Dis Sci 46:540-544
45. Roglans N, Vazquez-Carrera M, Alegret M, Novell F, Zambon D, Ros E, Laguna JC, Sanchez RM (2004) Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol 59:855-861
46. Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM (2001) Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21:1840-1845
47. Hudson K, Mojumder S, Day AJ (1983) The effect of bezafibrate and clofibrate on cholesterol ester metabolism in rabbit peritoneal macrophages stimulated with acetylated low density lipoproteins. Exp Mol Pathol 38:77-81
48. Kosters A, Frijters RJ, Schaap FG, Vink E, Plosch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK (2003) Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 38:710-716
49. Miyake JH, Wang SL, Davis RA (2000) Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. J Biol Chem 275:21805-21808
50. Bertolotti M, Gabbi C, Anzivino C, Mitro N, Godio C, De Fabiani E, Crestani M, Del Puppo M, Ricchi M, Carulli L, Rossi A, Loria P, Carulli N (2006) Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. Eur J Clin Invest 36:170-175